NCT05741489View on ClinicalTrials.gov

Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

March 9, 2023

Study Completion Date

March 9, 2023

Conditions
End Stage Kidney Disease
Interventions
DEVICE

Continuous glucose monitoring (CGM)

The Dexcom G6 CGM system is a compact, light-weight glucose testing device that measures glucose every 5 minutes. Participants will wear the CGM with the display off for 10 days while continuing their routine dialysis sessions.

Trial Locations (4)

30034

Emory Dialysis at Candler, Decatur

30303

Grady Memorial Hospital, Atlanta

30318

Emory Dialysis at Northside, Atlanta

30331

Emory Dialysis at Greenbriar, Atlanta

All Listed Sponsors
lead

Emory University

OTHER